Lv4
770 积分 2021-06-10 加入
Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis
4天前
已完结
Circumstances of Hospitalization Impact Outcomes of Pulmonary Embolism
4天前
已完结
Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year period
4天前
已完结
Surgical Management of Primary Pulmonary Artery Sarcoma
4个月前
已完结
Renin-angiotensin system regulates pulmonary arterial smooth muscle cell migration in chronic thromboembolic pulmonary hypertension
5个月前
已完结
Upcoming Clinical Trials in Critical Care, Diffuse Lung Disease, Pulmonary Vascular Disease, and Thoracic Oncology in 2024
6个月前
已完结
Imaging in Pulmonary Vascular Disease—Understanding Right Ventricle‐Pulmonary Artery Coupling
6个月前
已完结
Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism
7个月前
已完结
Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry
8个月前
已关闭
Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial
9个月前
已完结
口服多肽和蛋白质药物的研究进展
3年前
已采纳
甲状旁腺激素激动剂特立帕肽
3年前
已采纳
皖公网安备34019202002308
